tiprankstipranks
Trending News
More News >
OmniAb (OABI)
NASDAQ:OABI
US Market
Advertisement

OmniAb (OABI) Similar Stocks

Compare
204 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
OmniAb
$1.65
$241.85M
-57.91%
7 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$9.74
$260.02M
-60.28%
7 Buy
1 Hold
0 Sell
Strong Buy
Tiziana Life Sciences
$2.17
$219.58M
135.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
Atea Pharmaceuticals
$2.97
$230.93M
-12.65%
1 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$33.80
$244.13M
148.16%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sagimet Biosciences, Inc. Class A
$7.34
$226.62M
76.44%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OABI
OmniAb
1.65
-2.29
-58.12%
RNAC
Cartesian Therapeutics
9.74
-12.48
-56.17%
TLSA
Tiziana Life Sciences
2.17
1.22
128.42%
AVIR
Atea Pharmaceuticals
2.97
-0.43
-12.65%
VOR
Vor Biopharma
33.80
20.40
152.24%
SGMT
Sagimet Biosciences, Inc. Class A
7.34
3.18
76.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis